Oireachtas Joint and Select Committees

Wednesday, 8 November 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion (Resumed)

9:00 am

Mr. John Hennessy:

As a matter of course, generally the HSE would appeal to the companies to lodge their applications with all their information, including their final best-price offer. It is not helpful for companies to be coming in at a high price and then being prepared to come down subsequent to decisions being taken. All that achieves is delaying the process and keeping a protracted process going. Our preference would be to conduct a clean process and have the absolute bottom-line price on the table from the word go.

Comments

No comments

Log in or join to post a public comment.